|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.05 USD | +0.83% |
|
+2.29% | -3.49% |
| 08/04 | Goldman Sachs Adjusts PT on Molson Coors Beverage to $48 From $50, Maintains Buy Rating | MT |
| 08/04 | Wells Fargo Adjusts PT on Molson Coors Beverage to $45 From $52, Maintains Equalweight Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.52 | 2.64 | 3.83 | 4.32 | 4.29 | |||||
Return on Total Capital | 4.56 | 3.46 | 5.06 | 5.71 | 5.68 | |||||
Return On Equity % | 7.67 | -1.4 | 7.26 | 8.61 | -18.17 | |||||
Return on Common Equity | 7.8 | -1.34 | 7.33 | 8.54 | -18.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 39.43 | 34.16 | 37.33 | 38.99 | 38.37 | |||||
SG&A Margin | 22.28 | 21.66 | 21.9 | 21.64 | 23.33 | |||||
EBITDA Margin % | 22.53 | 16.96 | 19.5 | 21.3 | 21.21 | |||||
EBITA Margin % | 17.15 | 12.5 | 15.44 | 17.35 | 16.89 | |||||
EBIT Margin % | 15.03 | 10.56 | 13.66 | 15.57 | 15.04 | |||||
Income From Continuing Operations Margin % | 9.81 | -1.74 | 8.17 | 9.96 | -19.57 | |||||
Net Income Margin % | 9.78 | -1.64 | 8.11 | 9.65 | -19.2 | |||||
Net Avail. For Common Margin % | 9.78 | -1.64 | 8.11 | 9.65 | -19.2 | |||||
Normalized Net Income Margin | 7.78 | 5.23 | 7.49 | 8.13 | 8.56 | |||||
Levered Free Cash Flow Margin | 7.75 | 6.14 | 10.03 | 7.98 | 6.28 | |||||
Unlevered Free Cash Flow Margin | 9.27 | 7.53 | 11.23 | 9.46 | 7.62 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.4 | 0.45 | 0.44 | 0.46 | |||||
Fixed Assets Turnover | 2.36 | 2.47 | 2.6 | 2.5 | 2.32 | |||||
Receivables Turnover (Average Receivables) | 16.96 | 15.09 | 15.63 | 16.03 | 15.96 | |||||
Inventory Turnover (Average Inventory) | 8.48 | 8.82 | 9.19 | 9.27 | 9.51 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.77 | 0.78 | 0.7 | 0.94 | 0.55 | |||||
Quick Ratio | 0.42 | 0.43 | 0.43 | 0.6 | 0.35 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | 0.44 | 0.51 | 0.63 | 0.34 | |||||
Days Sales Outstanding (Average Receivables) | 21.52 | 24.2 | 23.36 | 22.84 | 22.87 | |||||
Days Outstanding Inventory (Average Inventory) | 43.06 | 41.38 | 39.7 | 39.47 | 38.37 | |||||
Average Days Payable Outstanding | 109.81 | 108.1 | 113.03 | 108.16 | 106.52 | |||||
Cash Conversion Cycle (Average Days) | -45.23 | -42.52 | -49.98 | -45.85 | -45.28 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 54.64 | 51.93 | 47.89 | 47.23 | 61.77 | |||||
Total Debt / Total Capital | 35.33 | 34.18 | 32.38 | 32.08 | 38.18 | |||||
LT Debt/Equity | 50.04 | 48.5 | 40.76 | 46.65 | 38.18 | |||||
Long-Term Debt / Total Capital | 32.36 | 31.93 | 27.56 | 31.68 | 23.6 | |||||
Total Liabilities / Total Assets | 50.53 | 50.07 | 49.06 | 48.39 | 53.63 | |||||
EBIT / Interest Expense | 5.94 | 4.51 | 6.83 | 6.41 | 6.76 | |||||
EBITDA / Interest Expense | 9.18 | 7.53 | 10.1 | 9.07 | 9.9 | |||||
(EBITDA - Capex) / Interest Expense | 7.17 | 4.89 | 7.23 | 6.68 | 7.01 | |||||
Total Debt / EBITDA | 3.12 | 3.55 | 2.72 | 2.48 | 2.65 | |||||
Net Debt / EBITDA | 2.86 | 3.24 | 2.36 | 2.1 | 2.25 | |||||
Total Debt / (EBITDA - Capex) | 4 | 5.47 | 3.8 | 3.36 | 3.75 | |||||
Net Debt / (EBITDA - Capex) | 3.66 | 4.98 | 3.29 | 2.85 | 3.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.48 | 4.1 | 9.36 | -0.64 | -4.18 | |||||
Gross Profit, 1 Yr. Growth % | 6.78 | -9.82 | 19.52 | 3.77 | -5.71 | |||||
EBITDA, 1 Yr. Growth % | 5.33 | -21.66 | 25.77 | 8.54 | -4.58 | |||||
EBITA, 1 Yr. Growth % | 9.58 | -24.14 | 35.04 | 11.68 | -6.75 | |||||
EBIT, 1 Yr. Growth % | 11.24 | -26.9 | 41.56 | 13.24 | -7.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -206.64 | -118.49 | -612.82 | 21.05 | -288.32 | |||||
Net Income, 1 Yr. Growth % | -205.97 | -117.43 | -641.3 | 18.28 | -290.63 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.12 | -29.99 | 56.67 | 7.75 | 0.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -205.48 | -117.53 | -639.51 | 22.43 | -300.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.58 | 8.97 | 2.43 | -8.54 | 1.43 | |||||
Inventory, 1 Yr. Growth % | 21.14 | -1.47 | 1.19 | -9.29 | -1.64 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.71 | 1.02 | 6.65 | 0.09 | 6.74 | |||||
Total Assets, 1 Yr. Growth % | 1.05 | -6.34 | 1.96 | -1.18 | -12.76 | |||||
Tangible Book Value, 1 Yr. Growth % | -17.98 | -10.3 | -12.19 | -1.24 | -20.91 | |||||
Common Equity, 1 Yr. Growth % | 8.51 | -5.42 | 3.99 | -0.79 | -21.86 | |||||
Cash From Operations, 1 Yr. Growth % | -7.21 | -4.54 | 38.42 | -8.11 | -6.59 | |||||
Capital Expenditures, 1 Yr. Growth % | -9.08 | 26.56 | 1.53 | 0.39 | 6.3 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -24.11 | -17.59 | 78.72 | -20.93 | -25.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -21.48 | -15.45 | 63.13 | -16.34 | -23.54 | |||||
Dividend Per Share, 1 Yr. Growth % | 19.3 | 123.53 | 7.89 | 7.32 | 6.82 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.43 | 5.28 | 6.69 | 4.24 | -2.43 | |||||
Gross Profit, 2 Yr. CAGR % | -1.77 | -1.87 | 3.82 | 11.37 | -1.08 | |||||
EBITDA, 2 Yr. CAGR % | -0.27 | -9.16 | -0.74 | 16.85 | 1.77 | |||||
EBITA, 2 Yr. CAGR % | 1.18 | -8.83 | 1.21 | 22.83 | 2.05 | |||||
EBIT, 2 Yr. CAGR % | 1.46 | -9.83 | 1.73 | 26.65 | 2.35 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 102.39 | -55.59 | -2.62 | 149.15 | 50.98 | |||||
Net Income, 2 Yr. CAGR % | 103.98 | -57.02 | -2.86 | 153.04 | 50.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.28 | -10.62 | 4.73 | 29.97 | 4.29 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 104.01 | -57 | -2.74 | 157 | 56.84 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.11 | 16.02 | 5.65 | -3.21 | -3.68 | |||||
Inventory, 2 Yr. CAGR % | 14.3 | 9.25 | -0.15 | -4.19 | -5.54 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -4.23 | -0.35 | 3.8 | 3.32 | 3.36 | |||||
Total Assets, 2 Yr. CAGR % | -2.17 | -2.71 | -2.28 | 0.38 | -7.15 | |||||
Tangible Book Value, 2 Yr. CAGR % | -12.51 | -14.22 | -11.25 | -6.87 | -11.62 | |||||
Common Equity, 2 Yr. CAGR % | -0.01 | 1.3 | -0.83 | 1.57 | -11.95 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.93 | -5.88 | 14.95 | 12.78 | -7.36 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.19 | 7.27 | 13.35 | 0.96 | 3.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -14.22 | -20.92 | 21.36 | 18.91 | -23.06 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.52 | -18.52 | 17.44 | 16.85 | -19.85 | |||||
Dividend Per Share, 2 Yr. CAGR % | -41.1 | 63.3 | 55.3 | 7.61 | 7.07 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.54 | 0.38 | 6.62 | 4.19 | 1.35 | |||||
Gross Profit, 3 Yr. CAGR % | -1.06 | -4.53 | 4.8 | 3.8 | 5.36 | |||||
EBITDA, 3 Yr. CAGR % | 0.44 | -7.98 | 1.24 | 2.26 | 9.22 | |||||
EBITA, 3 Yr. CAGR % | 1.56 | -8.08 | 3.93 | 4.59 | 12.05 | |||||
EBIT, 3 Yr. CAGR % | 1.93 | -9.04 | 4.8 | 5.43 | 14.06 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -3.85 | -8.84 | 0.38 | 4.71 | 126.95 | |||||
Net Income, 3 Yr. CAGR % | -3.42 | -10.15 | -0 | 3.73 | 130.24 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.16 | -9.86 | 7.77 | 5.73 | 19.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.56 | -9.97 | -0.08 | 5.01 | 136.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.44 | 1.58 | 11.3 | 0.69 | -1.69 | |||||
Inventory, 3 Yr. CAGR % | 10.79 | 8.79 | 6.49 | -3.29 | -3.35 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.19 | -2.51 | 1.93 | 2.55 | 4.45 | |||||
Total Assets, 3 Yr. CAGR % | -2.84 | -3.58 | -1.18 | -1.91 | -4.21 | |||||
Tangible Book Value, 3 Yr. CAGR % | -10.96 | -11.78 | -13.55 | -8.03 | -11.81 | |||||
Common Equity, 3 Yr. CAGR % | -0.22 | -1.85 | 2.19 | -0.81 | -6.93 | |||||
Cash From Operations, 3 Yr. CAGR % | -12.28 | -7.49 | 7.03 | 6.68 | 5.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.09 | 3.66 | 5.32 | 8.86 | 2.71 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -8.27 | -15.36 | 3.78 | 5.21 | 2.14 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -7.68 | -13.5 | 2.69 | 4.89 | 1.79 | |||||
Dividend Per Share, 3 Yr. CAGR % | -25.43 | -8.13 | 42.23 | 37.3 | 7.34 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.04 | -0.55 | 1.67 | 1.91 | 2.91 | |||||
Gross Profit, 5 Yr. CAGR % | 15.55 | -5.17 | 0.86 | 1.53 | 2.4 | |||||
EBITDA, 5 Yr. CAGR % | 21.81 | -7.12 | -0.04 | 1.24 | 1.45 | |||||
EBITA, 5 Yr. CAGR % | 25.35 | -8.22 | 1.42 | 3.21 | 3.17 | |||||
EBIT, 5 Yr. CAGR % | 25.95 | -9.22 | 1.85 | 3.82 | 3.81 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -8.82 | -34.84 | -3.36 | 36.29 | 18.18 | |||||
Net Income, 5 Yr. CAGR % | -8.8 | -35.46 | -3.2 | 35.95 | 17.66 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.55 | -9.14 | 4.39 | 4.34 | 6.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -9.16 | -35.45 | -3.23 | 36.96 | 19.67 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.2 | 0.31 | 0.59 | -0.37 | 5.05 | |||||
Inventory, 5 Yr. CAGR % | 6.31 | 6.04 | 6.28 | 3.4 | 1.51 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.88 | -1.4 | 0.16 | -0.22 | 2.5 | |||||
Total Assets, 5 Yr. CAGR % | -1.2 | -3.08 | -2.61 | -2.02 | -3.61 | |||||
Tangible Book Value, 5 Yr. CAGR % | -11.13 | -11.09 | -11.07 | -9.85 | -12.78 | |||||
Common Equity, 5 Yr. CAGR % | 3.28 | -0.45 | -0.47 | -0.49 | -3.72 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.9 | -4.25 | -2.26 | 0.14 | 1.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.86 | 1.98 | 0.6 | 2.57 | 4.51 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 0.65 | -12.08 | 2.6 | -3.04 | -7.8 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.73 | -11.03 | 1.65 | -2.46 | -6.89 | |||||
Dividend Per Share, 5 Yr. CAGR % | -16.14 | -1.51 | 0 | -2.13 | 26.96 |
- Stock Market
- Equities
- TAP Stock
- Financials Molson Coors Beverage Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















